Exit events / 16
#16
| id | 16 |
|---|---|
| company_id | 2042 |
| event_type | ipo |
| event_date | 2026-05-22 |
| counterparty_company_id | — |
| successor_company_id | — |
| deal_value_usd | 300000000 |
| deal_value_basis | — |
| notes | Aragen Life Sciences (Goldman + Quadria-backed) in talks for ~$300M Mumbai IPO; per PitchBook 2026-05-22 |
| source_urls | — |
| payload | {} |
| entered_by_person_id | — |
| entered_at | 2026-05-26T15:16:00.962479+00:00 |
| data_source | PitchBook 2026-05-22 |
| data_confidence | reported |